Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jul;104(1):103-7.
doi: 10.1007/s10549-006-9396-4. Epub 2006 Oct 24.

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

Yan Cui  1 , Esther A Koop, Paul J van Diest, Rita A Kandel, Thomas E Rohan
Affiliations
Randomized Controlled Trial

Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer

Yan Cui et al. Breast Cancer Res Treat. 2007 Jul.

Abstract

Certain nuclear morphometric features measured in breast tumor tissue have been shown to predict the prognosis of breast cancer patients. However, the application of these features to predicting risk of breast cancer development has received little attention. We conducted a case-control study to evaluate nuclear morphometric features in benign breast tissue in association with subsequent breast cancer risk. The study was nested within a cohort of 4,888 women with a histopathologic diagnosis of benign breast disease (BBD) and involved 61 cases and 71 controls, amongst whom there were 53 matched case-control sets. Conditional logistic regression models were fitted to assess various measurements of nuclear size and nuclear shape factors in relation to subsequent breast cancer risk. In multivariate analysis, subsequent breast cancer risk was positively associated with a nuclear shape factor that takes the shortest nuclear axis and the longest nuclear axis into consideration simultaneously (highest quartile versus lowest 3 quartiles: odds ratio = 3.07, 95% confidence limits = 1.61, 5.84). In contrast, there was no alteration in subsequent breast cancer risk in association with nuclear size features and other shape factors. In conclusion, our study results suggest that the shape factor that takes both the shortest nuclear axis and the longest nuclear axis into consideration might be of value to predict subsequent development of breast cancer among women with BBD.

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1158/1055-9965.EPI-04-0157', 'is_inner': False, 'url': 'https://doi.org/10.1158/1055-9965.epi-04-0157'}, {'type': 'PubMed', 'value': '15824141', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15824141/'}]}
    2. Colditz GA (2005) Epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev 14(4): 768–772 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9870852', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9870852/'}]}
    2. Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122(12): 1053–1055 - PubMed
    1. None
    2. Rohan TE, Kandel RA (2002) Breast. In: Franco EL, Rohan TE (eds) Cancer precursors: epidemiology, detection, and prevention. Springer, New York
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2', 'is_inner': False, 'url': 'https://doi.org/10.1002/(sici)1096-9896(199902)187:3<272::aid-path265>3.0.co;2-2'}, {'type': 'PubMed', 'value': '10398078', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10398078/'}]}
    2. Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187(3): 272–278 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMe058111', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejme058111'}, {'type': 'PubMed', 'value': '16034016', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16034016/'}]}
    2. Elmore JG, Gigerenzer G (2005) Benign breast disease–the risks of communicating risk. N Engl J Med 353(3): 297–299 - PubMed

Publication types